Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific
Published on January 08, 2025 by Banzai